Reset filters
  • 28 October 2008

Raltegravir resistance patterns becoming clearer

Read the article
  • 28 October 2008

Vicriviroc: long-term safety concerns over cancers dispelled

Read the article
  • 27 October 2008

Start treatment at CD4 cell counts below 500, says large cohort study

Read the article
  • 27 October 2008

Continued antiretroviral therapy reduces bone mineral density in SMART study

Read the article
  • 27 October 2008

Darunavir effective and tolerable in treatment-experienced children and adolescents at 48 weeks

Read the article
  • 27 October 2008

Bevirimat: good results at 400 mg liquid dose, but formulation problems persist

Read the article
  • 27 October 2008

No significant differences between elvucitabine and 3TC at 48 weeks

Read the article
  • 27 October 2008

Raltegravir non-inferior to efavirenz: 48 week, phase III results

Read the article
  • 23 October 2008

CD4 decline, death more likely if change from NNRTI regimen delayed

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.